SCHEMBL2337508

SCHEMBL2337508

CN(C)C=NC(=O)c1ccccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
LMNA P02545 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
NAPRT Q6XQN6 1/20 0.48
P4HTM Q9NXG6 1/20 0.48
GAA P10253 2/20 0.46
RAB9A P51151 5/20 0.45
NPC1 O15118 4/20 0.45
MAPT P10636 2/20 0.45
PKM P14618 2/20 0.45
POLB P06746 1/20 0.45
GFER P55789 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KDM4E B2RXH2 3/20 0.44
KMT2A Q03164 2/20 0.44
GSK3B P49841 1/20 0.43
MAPK1 P28482 2/20 0.43
HSD17B10 Q99714 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8125676 1.00 ALDH1A1 (0.52) ALDH1A1CES2CES1LMNAL3MBTL1
SCHEMBL2337504 1.00 ALDH1A1 (0.52) ALDH1A1CES2CES1LMNAL3MBTL1
SCHEMBL28260619 0.78 NPC1 (0.64) ALDH1A1L3MBTL1GAARAB9ANPC1
SCHEMBL28275739 0.78 NPC1 (0.64) ALDH1A1L3MBTL1GAARAB9ANPC1
SCHEMBL11259148 0.76 KDM4E (0.48) ALDH1A1NAPRTGAARAB9ANPC1
SCHEMBL11257339 0.76 KDM4E (0.48) ALDH1A1NAPRTGAARAB9ANPC1
SCHEMBL1279794 0.76 ALDH1A1 (0.61) ALDH1A1CES2CES1LMNAL3MBTL1
SCHEMBL155124 0.76 ALDH1A1 (0.50) ALDH1A1LMNAL3MBTL1GAARAB9A
SCHEMBL155125 0.76 ALDH1A1 (0.50) ALDH1A1LMNAL3MBTL1GAARAB9A
SCHEMBL2006799 0.75 CES2 (0.64) ALDH1A1CES2CES1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2358718-A1 MTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE MTOR/P13K/AKT PATHWAY Signal Pharmaceuticals, LLC (US) 2011-08-24 EP disclosed
WO-2010062571-A1 MTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE MTOR/P13K/AKT PATHWAY SIGNAL PHARMACEUTICALS, LLC (US) 2010-06-03 WO disclosed
EP-2078016-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051493-A2 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND THEIR USE AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed
EP-1007525-A1 AMINOMETYL OXOOXAZOLIDINYL BENZENE DERIVATIVES ZENECA LIMITED (GB) 2000-06-14 EP disclosed
WO-1999011642-A1 AMINOMETYL OXOOXAZOLIDINYL BENZENE DERIVATIVES ZENECA LIMITED (GB) 1999-03-11 WO disclosed